 | • レポートコード：MRC2-11QY12040 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は老年医学のグローバル市場について調査・分析したレポートです。種類別（鎮痛薬、降圧薬、スタチン、抗糖尿病薬、プロトンポンプ阻害薬、抗凝固薬、抗精神病薬、抗うつ薬）市場規模、用途別（心臓血管、関節炎、神経、癌、骨粗鬆症、呼吸器）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別老年医学の競争状況、市場シェア ・世界の老年医学市場：種類別市場規模 2015年-2020年（鎮痛薬、降圧薬、スタチン、抗糖尿病薬、プロトンポンプ阻害薬、抗凝固薬、抗精神病薬、抗うつ薬） ・世界の老年医学市場：種類別市場規模予測 2021年-2026年（鎮痛薬、降圧薬、スタチン、抗糖尿病薬、プロトンポンプ阻害薬、抗凝固薬、抗精神病薬、抗うつ薬） ・世界の老年医学市場：用途別市場規模 2015年-2020年（心臓血管、関節炎、神経、癌、骨粗鬆症、呼吸器） ・世界の老年医学市場：用途別市場規模予測 2021年-2026年（心臓血管、関節炎、神経、癌、骨粗鬆症、呼吸器） ・北米の老年医学市場分析：米国、カナダ ・ヨーロッパの老年医学市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの老年医学市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の老年医学市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの老年医学市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GSK、Boehringer Ingelheim、Novartis、Bristol-Myers Squibb、Pfizer、Eli Lilly、Abbott、AstraZeneca、Merck、Sanofi S.A. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Geriatrics, or geriatric medicine, is a specialty that focuses on health care of elderly people. It aims to promote health by preventing and treating diseases and disabilities in older adults
One of the key factors attributing to its rapid growth include rapidly increasing geriatric population base. Furthermore, the rising prevalence of various target diseases, decreasing immunity levels, and the significant improvements in the healthcare systems across the globe is also significantly driving the market growth.
Market Analysis and Insights: Global Geriatric Medicine Market
The global Geriatric Medicine market size is projected to reach US$ 518720 million by 2026, from US$ 497140 million in 2020, at a CAGR of 4.0%% during 2021-2026.
Global Geriatric Medicine Scope and Market Size
Geriatric Medicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Geriatric Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
GSK
Boehringer Ingelheim
Novartis
Bristol-Myers Squibb
Pfizer
Eli Lilly
Abbott
AstraZeneca
Merck
Sanofi S.A.
Market segment by Type, the product can be split into
Analgesics
Antihypertensives
Statins
Antidiabetics
Proton Pump Inhibitor
Anticoagulant
Antipsychotic
Antidepressant
Market segment by Application, split into
Cardiovascular
Arthritis
Neurological
Cancer
Osteoporosis
Respiratory
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Geriatric Medicine Revenue
1.4 Market by Type
1.4.1 Global Geriatric Medicine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Analgesics
1.4.3 Antihypertensives
1.4.4 Statins
1.4.5 Antidiabetics
1.4.6 Proton Pump Inhibitor
1.4.7 Anticoagulant
1.4.8 Antipsychotic
1.4.9 Antidepressant
1.5 Market by Application
1.5.1 Global Geriatric Medicine Market Share by Application: 2020 VS 2026
1.5.2 Cardiovascular
1.5.3 Arthritis
1.5.4 Neurological
1.5.5 Cancer
1.5.6 Osteoporosis
1.5.7 Respiratory
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Geriatric Medicine Market Perspective (2015-2026)
2.2 Global Geriatric Medicine Growth Trends by Regions
2.2.1 Geriatric Medicine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Geriatric Medicine Historic Market Share by Regions (2015-2020)
2.2.3 Geriatric Medicine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Geriatric Medicine Market Growth Strategy
2.3.6 Primary Interviews with Key Geriatric Medicine Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Geriatric Medicine Players by Market Size
3.1.1 Global Top Geriatric Medicine Players by Revenue (2015-2020)
3.1.2 Global Geriatric Medicine Revenue Market Share by Players (2015-2020)
3.1.3 Global Geriatric Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Geriatric Medicine Market Concentration Ratio
3.2.1 Global Geriatric Medicine Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Geriatric Medicine Revenue in 2019
3.3 Geriatric Medicine Key Players Head office and Area Served
3.4 Key Players Geriatric Medicine Product Solution and Service
3.5 Date of Enter into Geriatric Medicine Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Geriatric Medicine Historic Market Size by Type (2015-2020)
4.2 Global Geriatric Medicine Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Geriatric Medicine Market Size by Application (2015-2020)
5.2 Global Geriatric Medicine Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Geriatric Medicine Market Size (2015-2020)
6.2 Geriatric Medicine Key Players in North America (2019-2020)
6.3 North America Geriatric Medicine Market Size by Type (2015-2020)
6.4 North America Geriatric Medicine Market Size by Application (2015-2020)
7 Europe
7.1 Europe Geriatric Medicine Market Size (2015-2020)
7.2 Geriatric Medicine Key Players in Europe (2019-2020)
7.3 Europe Geriatric Medicine Market Size by Type (2015-2020)
7.4 Europe Geriatric Medicine Market Size by Application (2015-2020)
8 China
8.1 China Geriatric Medicine Market Size (2015-2020)
8.2 Geriatric Medicine Key Players in China (2019-2020)
8.3 China Geriatric Medicine Market Size by Type (2015-2020)
8.4 China Geriatric Medicine Market Size by Application (2015-2020)
9 Japan
9.1 Japan Geriatric Medicine Market Size (2015-2020)
9.2 Geriatric Medicine Key Players in Japan (2019-2020)
9.3 Japan Geriatric Medicine Market Size by Type (2015-2020)
9.4 Japan Geriatric Medicine Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Geriatric Medicine Market Size (2015-2020)
10.2 Geriatric Medicine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Geriatric Medicine Market Size by Type (2015-2020)
10.4 Southeast Asia Geriatric Medicine Market Size by Application (2015-2020)
11 India
11.1 India Geriatric Medicine Market Size (2015-2020)
11.2 Geriatric Medicine Key Players in India (2019-2020)
11.3 India Geriatric Medicine Market Size by Type (2015-2020)
11.4 India Geriatric Medicine Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Geriatric Medicine Market Size (2015-2020)
12.2 Geriatric Medicine Key Players in Central & South America (2019-2020)
12.3 Central & South America Geriatric Medicine Market Size by Type (2015-2020)
12.4 Central & South America Geriatric Medicine Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GSK
13.1.1 GSK Company Details
13.1.2 GSK Business Overview
13.1.3 GSK Geriatric Medicine Introduction
13.1.4 GSK Revenue in Geriatric Medicine Business (2015-2020))
13.1.5 GSK Recent Development
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Details
13.2.2 Boehringer Ingelheim Business Overview
13.2.3 Boehringer Ingelheim Geriatric Medicine Introduction
13.2.4 Boehringer Ingelheim Revenue in Geriatric Medicine Business (2015-2020)
13.2.5 Boehringer Ingelheim Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Geriatric Medicine Introduction
13.3.4 Novartis Revenue in Geriatric Medicine Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Bristol-Myers Squibb
13.4.1 Bristol-Myers Squibb Company Details
13.4.2 Bristol-Myers Squibb Business Overview
13.4.3 Bristol-Myers Squibb Geriatric Medicine Introduction
13.4.4 Bristol-Myers Squibb Revenue in Geriatric Medicine Business (2015-2020)
13.4.5 Bristol-Myers Squibb Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview
13.5.3 Pfizer Geriatric Medicine Introduction
13.5.4 Pfizer Revenue in Geriatric Medicine Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 Eli Lilly
13.6.1 Eli Lilly Company Details
13.6.2 Eli Lilly Business Overview
13.6.3 Eli Lilly Geriatric Medicine Introduction
13.6.4 Eli Lilly Revenue in Geriatric Medicine Business (2015-2020)
13.6.5 Eli Lilly Recent Development
13.7 Abbott
13.7.1 Abbott Company Details
13.7.2 Abbott Business Overview
13.7.3 Abbott Geriatric Medicine Introduction
13.7.4 Abbott Revenue in Geriatric Medicine Business (2015-2020)
13.7.5 Abbott Recent Development
13.8 AstraZeneca
13.8.1 AstraZeneca Company Details
13.8.2 AstraZeneca Business Overview
13.8.3 AstraZeneca Geriatric Medicine Introduction
13.8.4 AstraZeneca Revenue in Geriatric Medicine Business (2015-2020)
13.8.5 AstraZeneca Recent Development
13.9 Merck
13.9.1 Merck Company Details
13.9.2 Merck Business Overview
13.9.3 Merck Geriatric Medicine Introduction
13.9.4 Merck Revenue in Geriatric Medicine Business (2015-2020)
13.9.5 Merck Recent Development
13.10 Sanofi S.A.
13.10.1 Sanofi S.A. Company Details
13.10.2 Sanofi S.A. Business Overview
13.10.3 Sanofi S.A. Geriatric Medicine Introduction
13.10.4 Sanofi S.A. Revenue in Geriatric Medicine Business (2015-2020)
13.10.5 Sanofi S.A. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Geriatric Medicine Key Market Segments
Table 2. Key Players Covered: Ranking by Geriatric Medicine Revenue
Table 3. Ranking of Global Top Geriatric Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Geriatric Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Analgesics
Table 6. Key Players of Antihypertensives
Table 7. Key Players of Statins
Table 8. Key Players of Antidiabetics
Table 9. Key Players of Proton Pump Inhibitor
Table 10. Key Players of Anticoagulant
Table 11. Key Players of Antipsychotic
Table 12. Key Players of Antidepressant
Table 13. Global Geriatric Medicine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Geriatric Medicine Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Geriatric Medicine Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Geriatric Medicine Market Share by Regions (2015-2020)
Table 17. Global Geriatric Medicine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Geriatric Medicine Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Geriatric Medicine Market Growth Strategy
Table 23. Main Points Interviewed from Key Geriatric Medicine Players
Table 24. Global Geriatric Medicine Revenue by Players (2015-2020) (Million US$)
Table 25. Global Geriatric Medicine Market Share by Players (2015-2020)
Table 26. Global Top Geriatric Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Geriatric Medicine as of 2019)
Table 27. Global Geriatric Medicine by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Geriatric Medicine Product Solution and Service
Table 30. Date of Enter into Geriatric Medicine Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Geriatric Medicine Market Size by Type (2015-2020) (Million US$)
Table 33. Global Geriatric Medicine Market Size Share by Type (2015-2020)
Table 34. Global Geriatric Medicine Revenue Market Share by Type (2021-2026)
Table 35. Global Geriatric Medicine Market Size Share by Application (2015-2020)
Table 36. Global Geriatric Medicine Market Size by Application (2015-2020) (Million US$)
Table 37. Global Geriatric Medicine Market Size Share by Application (2021-2026)
Table 38. North America Key Players Geriatric Medicine Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Geriatric Medicine Market Share (2019-2020)
Table 40. North America Geriatric Medicine Market Size by Type (2015-2020) (Million US$)
Table 41. North America Geriatric Medicine Market Share by Type (2015-2020)
Table 42. North America Geriatric Medicine Market Size by Application (2015-2020) (Million US$)
Table 43. North America Geriatric Medicine Market Share by Application (2015-2020)
Table 44. Europe Key Players Geriatric Medicine Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Geriatric Medicine Market Share (2019-2020)
Table 46. Europe Geriatric Medicine Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Geriatric Medicine Market Share by Type (2015-2020)
Table 48. Europe Geriatric Medicine Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Geriatric Medicine Market Share by Application (2015-2020)
Table 50. China Key Players Geriatric Medicine Revenue (2019-2020) (Million US$)
Table 51. China Key Players Geriatric Medicine Market Share (2019-2020)
Table 52. China Geriatric Medicine Market Size by Type (2015-2020) (Million US$)
Table 53. China Geriatric Medicine Market Share by Type (2015-2020)
Table 54. China Geriatric Medicine Market Size by Application (2015-2020) (Million US$)
Table 55. China Geriatric Medicine Market Share by Application (2015-2020)
Table 56. Japan Key Players Geriatric Medicine Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Geriatric Medicine Market Share (2019-2020)
Table 58. Japan Geriatric Medicine Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Geriatric Medicine Market Share by Type (2015-2020)
Table 60. Japan Geriatric Medicine Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Geriatric Medicine Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Geriatric Medicine Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Geriatric Medicine Market Share (2019-2020)
Table 64. Southeast Asia Geriatric Medicine Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Geriatric Medicine Market Share by Type (2015-2020)
Table 66. Southeast Asia Geriatric Medicine Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Geriatric Medicine Market Share by Application (2015-2020)
Table 68. India Key Players Geriatric Medicine Revenue (2019-2020) (Million US$)
Table 69. India Key Players Geriatric Medicine Market Share (2019-2020)
Table 70. India Geriatric Medicine Market Size by Type (2015-2020) (Million US$)
Table 71. India Geriatric Medicine Market Share by Type (2015-2020)
Table 72. India Geriatric Medicine Market Size by Application (2015-2020) (Million US$)
Table 73. India Geriatric Medicine Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Geriatric Medicine Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Geriatric Medicine Market Share (2019-2020)
Table 76. Central & South America Geriatric Medicine Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Geriatric Medicine Market Share by Type (2015-2020)
Table 78. Central & South America Geriatric Medicine Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Geriatric Medicine Market Share by Application (2015-2020)
Table 80. GSK Company Details
Table 81. GSK Business Overview
Table 82. GSK Product
Table 83. GSK Revenue in Geriatric Medicine Business (2015-2020) (Million US$)
Table 84. GSK Recent Development
Table 85. Boehringer Ingelheim Company Details
Table 86. Boehringer Ingelheim Business Overview
Table 87. Boehringer Ingelheim Product
Table 88. Boehringer Ingelheim Revenue in Geriatric Medicine Business (2015-2020) (Million US$)
Table 89. Boehringer Ingelheim Recent Development
Table 90. Novartis Company Details
Table 91. Novartis Business Overview
Table 92. Novartis Product
Table 93. Novartis Revenue in Geriatric Medicine Business (2015-2020) (Million US$)
Table 94. Novartis Recent Development
Table 95. Bristol-Myers Squibb Company Details
Table 96. Bristol-Myers Squibb Business Overview
Table 97. Bristol-Myers Squibb Product
Table 98. Bristol-Myers Squibb Revenue in Geriatric Medicine Business (2015-2020) (Million US$)
Table 99. Bristol-Myers Squibb Recent Development
Table 100. Pfizer Company Details
Table 101. Pfizer Business Overview
Table 102. Pfizer Product
Table 103. Pfizer Revenue in Geriatric Medicine Business (2015-2020) (Million US$)
Table 104. Pfizer Recent Development
Table 105. Eli Lilly Company Details
Table 106. Eli Lilly Business Overview
Table 107. Eli Lilly Product
Table 108. Eli Lilly Revenue in Geriatric Medicine Business (2015-2020) (Million US$)
Table 109. Eli Lilly Recent Development
Table 110. Abbott Company Details
Table 111. Abbott Business Overview
Table 112. Abbott Product
Table 113. Abbott Revenue in Geriatric Medicine Business (2015-2020) (Million US$)
Table 114. Abbott Recent Development
Table 115. AstraZeneca Business Overview
Table 116. AstraZeneca Product
Table 117. AstraZeneca Company Details
Table 118. AstraZeneca Revenue in Geriatric Medicine Business (2015-2020) (Million US$)
Table 119. AstraZeneca Recent Development
Table 120. Merck Company Details
Table 121. Merck Business Overview
Table 122. Merck Product
Table 123. Merck Revenue in Geriatric Medicine Business (2015-2020) (Million US$)
Table 124. Merck Recent Development
Table 125. Sanofi S.A. Company Details
Table 126. Sanofi S.A. Business Overview
Table 127. Sanofi S.A. Product
Table 128. Sanofi S.A. Revenue in Geriatric Medicine Business (2015-2020) (Million US$)
Table 129. Sanofi S.A. Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Geriatric Medicine Market Share by Type: 2020 VS 2026
Figure 2. Analgesics Features
Figure 3. Antihypertensives Features
Figure 4. Statins Features
Figure 5. Antidiabetics Features
Figure 6. Proton Pump Inhibitor Features
Figure 7. Anticoagulant Features
Figure 8. Antipsychotic Features
Figure 9. Antidepressant Features
Figure 10. Global Geriatric Medicine Market Share by Application: 2020 VS 2026
Figure 11. Cardiovascular Case Studies
Figure 12. Arthritis Case Studies
Figure 13. Neurological Case Studies
Figure 14. Cancer Case Studies
Figure 15. Osteoporosis Case Studies
Figure 16. Respiratory Case Studies
Figure 17. Geriatric Medicine Report Years Considered
Figure 18. Global Geriatric Medicine Market Size YoY Growth 2015-2026 (US$ Million)
Figure 19. Global Geriatric Medicine Market Share by Regions: 2020 VS 2026
Figure 20. Global Geriatric Medicine Market Share by Regions (2021-2026)
Figure 21. Porter's Five Forces Analysis
Figure 22. Global Geriatric Medicine Market Share by Players in 2019
Figure 23. Global Top Geriatric Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Geriatric Medicine as of 2019
Figure 24. The Top 10 and 5 Players Market Share by Geriatric Medicine Revenue in 2019
Figure 25. North America Geriatric Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Europe Geriatric Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. China Geriatric Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Japan Geriatric Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Southeast Asia Geriatric Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. India Geriatric Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Central & South America Geriatric Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 32. Bottom-up and Top-down Approaches for This Report
Figure 33. Data Triangulation
Figure 34. Key Executives Interviewed
高齢者用携帯電話の世界市場（～2026年） The geriatric cellular phone is a senior citizen-friendly phone that bears long-battery life and large font size. The geriatric cellular phone includes a flashlight along with a magnifier to enlarge the words on the screen. Moreover, the cellular phone allows users to set more than one SOS numbers f…- ゲノム医療の世界市場（～2026年） Market Analysis and Insights: Global Genomic Medicine Market The global Genomic Medicine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Genomic Medicine Scope and Market Size Genomic Medicine market is segmented by Ty…
- スポーツ医療の世界市場（～2026年） Sports medicine pertains to the treatment and prevention of injuries resulting from sports and athletic activities. Sports injuries involve both bone and soft tissue injuries. The sports medicine market includes devices that are used for the prevention of sports injuries as well as for the cure, rec…
- ホメオパシー医薬品の世界市場（～2026年） Homeopathy is a field of alternative medicine, introduced by Samuel Hahnemann in 1976. It works on the principle of similarity of symptoms i.e. a substance causing symptoms of disease in healthy individual will show same symptoms in the sick. Homeopathic medicine include treatment using natural sour…
- AYUSH・代替医療の世界市場（～2026年） Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) is a system of alternative medicines in India. Growing population, rising awareness about AYUSH medicines, increasing side-effects of mainstream medicines, escalating costs of conventional health care and government support is dri…